Recreational cannabis is now legal in 18 states and the District of Columbia. Medical marijuana use is legal in 37. Legal U.S. cannabis industry sales are forecast to jump 23% to around $22.8 billion in 2021, according to cannabis industry market researcher Headset.
in 2022, those sales are expected to accelerate, growing 24% to $28.3 billion. Those are far bigger sales figures than in less populous Canada. There, legal cannabis sales are expected to hit $4.06 billion this year and $5.35 billion next year. That's a bigger percentage gain, but in a market where the largest producers are still grappling with losses and escalating competition.
***
The MJ ETF peaked when recreational cannabis went into effect in the fall of 2018 after staging a massive run leading up to the highly anticipated event.
Since then, the onus has been on companies to deliver. Most of them have begun reporting enviably strong sales growth, but the euphoric valuations had priced in a generous amount of future success.
The cannabis market is still nascent and the THC and CBD markets have tremendous long-term potential. Headwinds in the form of regulations and capacity constraints appear to be abating as the industry starts to mature. The growth outlook remains very promising.
See also : marijuana news
ETFs (by avg daily vol)
(see below for a detailed comparison)
ETFs (by avg daily vol)
(see below for a detailed comparison)
- MSOS AdvisorShare Pure U.S. Cannabis ETF
- MJ ETFMG Alternative Harvest ETF 457K
- THCX The Cannabis ETF 73K
- YOLO AdvisorShares Pure Cannabis ETF 50K
- TOKE Cambria Cannabis ETF 24K
- CNBS Amplify Seymour Cannabis ETF 15K
- (Toronto:HMMJ Horizons Marijuana Life Sciences Index ETF 176K)
MSOX
Stocks (by market cap)
Ticker Company name Mkt Cap▼
Ticker Company name Mkt Cap▼
- CGC Canopy Growth 8.715B; Ontario, Canada; Canopy has a deal in place to buy U.S. cannabis operator Acreage Holdings. In February 2021, CEO David Klein said Canopy could enter the U.S. legal market for THC products "during calendar 2021".
- TLRY Tilray 6.215B; Ontario, Canada; Tilray has merged with Aphria.
- CRON Cronos 2.69B; Toronto, Canada
- ACB Aurora Cannabis 1.348B; Edmonton, Canada; medical cannabis products. As of September 2018, it had eight licensed production facilities, five sales licenses, and operations in 18 countries.
- --------
- IIPR Innovative Industrial Properties 1.286B; a REIT that acquires industrial properties and rents space to marijuana growers.
- HEXO HEXO Corp. 1.171B; Quebec-based
- OGI Organigram 842.522M; Canada; The company’s stock began trading on the Nasdaq on May 21, 19. Previously it was traded in Canada and over the counter in the U.S.
- KSHB KushCo 440.088M; California; packaging supplies, vaporizer cartridges, heating technologies, batteries
- CTST CannTrust 361.912M; Ontario, Canada
- CRBP Corbus Pharmaceuticals 340.604M
- NBEV New Age Beverages 298.774M; Denver, Colorado
- ZYNE Zynerba Pharmaceuticals 260.90M; Developes next-generation transdermal cannabinoid therapeutics. Using the non-euphoric CBD, Zynerba wants to improve the lives of patients affected by rare neuropsychiatric conditions.
- PYX Pyxus Int'l 140.531M; Morrisville, North Carolina; Tobacco company with a minor investment made in a few cannabis operators.
- KERN Akerna 102.477M; Orlando, Florida
- SNDL Sundial Growers Aug 1, 19 IPO
++Turning Point Brands (NYSE:TPB)
++GRWG GrowGeneration , a hydroponics retailer
++CGRO
++HUGE
++YCBD
- GW Pharmaceuticals (NASDAQ:GWPH) (UK-based) was acquired by Ireland-based Jazz Pharmaceuticals (NASDAQ:JAZZ) for $7.6 billion. (Completed in May 2021)
- Aphria (APHA) acquired by Tilray (TLRY). (Dec 2020)
The majority of U.S.-based cannabis companies and many foreign American Depository Receipts (ADRs) trade over the counter (OTC). The over-the-counter markets typically have decreased liquidity and larger spreads compared to the large U.S. exchanges.
- TCNNF (OTCMKTS) Trulieve Cannabis 4.687B Quincy, Florida; focused on the medical markets in Florida
- --------------
- CURLF (OTCMKTS) Curaleaf 2.939B; Wakefield, Massachusetts; runs more than 100 dispensaries across more than 20 states.
- GTBIF (OTCMKTS) Green Thumb Industries 2.07B; Chicago, Illinois; most of its retail locations are in Pennsylvania and Illinois
- CRLBF (OTCMKTS) Cresco Labs 1.058B; Chicago, Illinois; draws a lot of revenue from its wholesale business
- CWBHF (OTCMKTS) Charlotte's Web 647.919M; Boulder, Colorado
- TGODF (OTCMKTS) The Green Organic Dutchman 644.674M; Mississauga, Canada
- ACRGF (OTCMKTS) Acreage Holdings 526.485M; NYC-based
- CVSI (OTCMKTS) CV Sciences 409.426M; Nevada-based
- ORHOF (OTCMKTS) Origin House 387.251M; Ottawa, Canada; Invests in the legal cannabis sector, prefers to take majority stake in companies.
- MMNFF (OTCMKTS) MedMen Enterprises 351.475M; Culver City, California
- GGBXF (OTCMKTS) Green Growth Brands 324.663M; Toronto, Canada; Offers cannabis, tetrahydro cannabidol, cannabidiol, and cannabis-infused consumer products, as well as technology and consulting services for the cannabis industry. As of June 12, 2019, it operated 50 Seventh Sense branded botanical therapy shops.
- SPRWF (OTCMKTS) The Supreme Cannabis Company 296.619M Toronto, Canada
- CURR (OTCMKTS) CURE Pharmaceutical 154.265M; Oxnard, California
- NXTTF (OTCMKTS) Namaste Technologies 125.366M; Vancouver, Canada
- VVCIF (OTCMKTS) VIVO Cannabis 113.304M; Canada
- TRTC (OTCMKTS) Terra Tech 54.163M; Irvine, California
- IMLFF (OTCMKTS) InMed Pharmaceuticals 43.592M; Vancouver, Canada; develops cannabinoid-based therapies
- CBDS (OTCMKTS) Cannabis Sativa 37.865M; Nevada; skin care products used to relieve pain for sore muscles, joints, arthritic, and back pain;
- CANN (OTCMKTS) General Cannabis 28.998M; Denver, Colorado
- FFLWF (OTCMKTS) Fire & Flower Holdings Corp.; 54.627M; Canada
July 2021: cannabis legalization spreads across the U.S. Eighteen states and Washington, D.C., have legalized cannabis for adult use. Thirty-seven states and D.C. allow medical marijuana.
Money is pouring into the legal cannabis market, potentially steering more U.S. consumers toward weed. Struggling beer and tobacco companies are using that trend to find new business. For example, cannabis drinks or sleek vaping devices and tins of prerolled joints.
Horizons Marijuana Life Sciences Index ETF - Canada
Canada's marijuana stocks launched their invasion of U.S. exchanges in February 2018, when Cronos Group (CRON) became the first straight-up pot company to list on the Nasdaq. In the months since, recreational pot use turned legal in Canada and seven other Canadian pot producers piled into U.S. exchanges competing to pick up mainstream credibility and a lot more investor cash.
Canopy Growth stock followed Cronos Group, listing on the New York Stock Exchange in May 2018. Canopy has since become the world's most valuable weed company, with a market capitalization of $9 billion.
Last July, Tilray followed, via an IPO — making it the first weed company to debut exclusively on a U.S. exchange. Every other Canadian pot producer trading on a U.S. exchange also trades in Canada.
Aurora Cannabis (ACB) listed on the NYSE in October, and Aphria (APHA) in November. Hexo hit the NYSE American in January. CannTrust landed on the NYSE in February, but CannTrust stock crashed after running afoul of regulators. Organigram (OGI) listed on the Nasdaq in May.
The companies can list on the U.S. platforms because they don't violate federal law in their own country.
Marijuana ETFs
Latin America
Legal sales in 2018 are estimated at $125 million, but analysts expect this to explode 100-fold to $12.7 billion by 2028.
No comments:
Post a Comment